Efficacy and Safety of Actonel ® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women
Condition: Postmenopausal Osteoporosis Interventions: Drug: Risedronate Sodium 35 MG [Actonel]; Drug: Calcium Vitamin D combination Sponsor: Dong-A ST Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials